Cargando…

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection represents a global health crisis. Immune cell activation via pattern recognition receptors has been implicated as a driver of the hyperinflammatory response seen in COVID-19. However, our understanding of the specific immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gebremeskel, Simon, Schanin, Julia, Coyle, Krysta M., Butuci, Melina, Luu, Thuy, Brock, Emily C., Xu, Alan, Wong, Alan, Leung, John, Korver, Wouter, Morin, Ryan D., Schleimer, Robert P., Bochner, Bruce S., Youngblood, Bradford A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988091/ https://www.ncbi.nlm.nih.gov/pubmed/33777047 http://dx.doi.org/10.3389/fimmu.2021.650331

Ejemplares similares

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
por: Korver, Wouter, et al.
Publicado: (2022)

Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022)

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
por: Schanin, Julia, et al.
Publicado: (2020)

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022)

Discovery, Function, and Therapeutic Targeting of Siglec-8
por: Youngblood, Bradford A., et al.
Publicado: (2020)

Mast cell activation is associated with post‐acute COVID‐19 syndrome
por: Wechsler, Joshua B., et al.
Publicado: (2021)

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
por: Cao, Yun, et al.
Publicado: (2023)

Glycobiology of Eosinophilic Inflammation: Contributions of Siglecs, Glycans, and Other Glycan-Binding Proteins
por: O’Sullivan, Jeremy A., et al.
Publicado: (2017)

Siglec-8 Signals Through a Non-Canonical Pathway to Cause Human Eosinophil Death In Vitro
por: Carroll, Daniela J., et al.
Publicado: (2021)

Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice
por: Wei, Yadong, et al.
Publicado: (2018)

Mechanisms of Siglec-F-Induced Eosinophil Apoptosis: A Role for Caspases but Not for SHP-1, Src Kinases, NADPH Oxidase or Reactive Oxygen
por: Mao, Hui, et al.
Publicado: (2013)

Glycomic analysis of human mast cells, eosinophils and basophils
por: North, Simon J, et al.
Publicado: (2012)

Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells
por: Yu, Yingxin, et al.
Publicado: (2018)

New Insights into the Mechanism of the Down-Regulation of Mast Cells in the Treatment of Interstitial Cystitis: Possible Role of Siglecs
por: Lee, Tack
Publicado: (2011)

Identification of a Siglec-F+ granulocyte-macrophage progenitor
por: Bolden, Jessica E., et al.
Publicado: (2018)

Siglec Ligands
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2021)

Mast cells and eosinophils in invasive breast carcinoma
por: Amini, Rose-Marie, et al.
Publicado: (2007)

Eosinophil peroxidase-induced mast cell secretion
Publicado: (1980)

Molecular cloning of porcine Siglec-3, Siglec-5 and Siglec-10, and identification of Siglec-10 as an alternative receptor for porcine reproductive and respiratory syndrome virus (PRRSV)
por: Xie, Jiexiong, et al.
Publicado: (2017)

Eosinophil Survival and Apoptosis in Health and Disease
por: Park, Yong Mean, et al.
Publicado: (2010)

Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways
por: Gonzalez-Gil, Anabel, et al.
Publicado: (2018)

Coevolution of Siglec-11 and Siglec-16 via gene conversion in primates
por: Hayakawa, Toshiyuki, et al.
Publicado: (2017)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
por: Bradding, Peter
Publicado: (2008)

Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9
por: Rodriguez, Ernesto, et al.
Publicado: (2021)

Biology and Function of Eosinophils in Chronic Rhinosinusitis With or Without Nasal Polyps
por: Bochner, Bruce S., et al.
Publicado: (2020)

Induction of Siglec-F(hi)CD101(hi) eosinophils in the lungs following murine hookworm Nippostrongylus brasiliensis infection
por: Chetty, Alisha, et al.
Publicado: (2023)

Broad and direct interaction between TLR and Siglec families of pattern recognition receptors and its regulation by Neu1
por: Chen, Guo-Yun, et al.
Publicado: (2014)

Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation
por: Vanheel, Hanne, et al.
Publicado: (2018)

Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2017)

Strong association of mast cells with eosinophilic esophagitis‐specific signatures
por: Alvarado, Diego, et al.
Publicado: (2022)

TLR signaling in mast cells: common and unique features
por: Sandig, Hilary, et al.
Publicado: (2012)

Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexity
por: Valent, Peter, et al.
Publicado: (2021)

Eosinophilic bioactivities in severe asthma
por: Carr, Tara F., et al.
Publicado: (2016)

Peripheral prion disease pathogenesis is unaltered in the absence of sialoadhesin (Siglec-1/CD169)
por: Bradford, Barry M, et al.
Publicado: (2014)

Siglecs at the Host–Pathogen Interface
por: Chang, Yung-Chi, et al.
Publicado: (2020)

Siglecs as Therapeutic Targets in Cancer
por: Lim, Jackwee, et al.
Publicado: (2021)

Siglec Signaling in the Tumor Microenvironment
por: van Houtum, Eline J. H., et al.
Publicado: (2021)

The Roles of Siglec7 and Siglec9 on Natural Killer Cells in Virus Infection and Tumour Progression
por: Zheng, Yayun, et al.
Publicado: (2020)

BGN/TLR4/NF-κB Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells
por: Huang, Hsiang-Chi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ch7917td9sm7c21ldasedj8bha